CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling
CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling
复制标题
DOI:
10.15252/embj.201899395
复制
发表时间:
2018-10-15
期刊:
影响因子:
11.4
通讯作者:
Hui, Kam Man
中科院分区:
文献类型:
--
作者:
Chen, Jianxiang;Rajasekaran, Muthukumar;Hui, Kam Man
Uncontrolled cell division is a hallmark of cancer. Deregulation of Wnt components has been linked to aberrant cell division by multiple mechanisms, including Wnt-mediated stabilisation of proteins signalling, which was notably observed in mitosis. Analysis of Wnt components revealed an unexpected role of B-cell CLL/lymphoma 9 (BCL9) in maintaining mitotic Wnt signalling to promote precise cell division and growth of cancer cell. Mitotic interactome analysis revealed a mechanistic role of BCL9 in inhibiting clathrin-mediated degradation of LRP6 signalosome components by interacting with clathrin and the components in Wnt destruction complex; this function was further controlled by CDK1-driven phosphorylation of BCL9N-terminal, especially T172. Interestingly, T172 phosphorylation was correlated with cancer patient prognosis and enriched in tumours. Thus, our results revealed a novel role of BCL9 in controlling mitotic Wnt signalling to promote cell division and growth.